Morgan Stanley Maintains Equal-Weight on Innovid, Raises Price Target to $1.4
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Brian Nowak maintains an Equal-Weight rating on Innovid (NYSE:CTV) and raises the price target from $1.1 to $1.4.
August 09, 2023 | 1:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Morgan Stanley maintains an Equal-Weight rating on Innovid (NYSE:CTV) and raises the price target from $1.1 to $1.4.
The raised price target by Morgan Stanley indicates a positive outlook for Innovid. This could potentially lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100